Target

metformin

4 abstracts

Abstract
Clinical outcomes with alpelisib (ALP) plus fulvestrant (FUL) in patients with HR-positive (HR+)/HER2-negative (HER2-) advanced breast cancer (ABC) with PIK3CA mutations (m) in routine practice at several Russian centers.
Org: Moscow Multidisciplinary Clinical Center "Kommunarka" of the Moscow Department of Health, Moscow, Russian Federation, SBIH Moscow Multidisciplinary Clinical Center "Kommunarka" of the Moscow Department of Health, Moscow, Russian Federation, Moscow City Oncology Hospital 62, Moscow, Russian Federation, Moscow City Oncology Hospital 62, Krasnogorskiy Rayon, Russian Federation, Moscow City Clinical Oncology Hospital No. 1, Moscow, Russian Federation,
Abstract
Impact of commonly prescribed medications on immune-related adverse events.
Org: Veterans Affairs Ann Arbor Healthcare System,
Abstract
Cardiotoxicity surveillance among patients with cancer treated with immunotherapy.
Org: Oncoclinicas Paraiba (Centro Paraibano de Oncologia), Hospital Universitário Lauro Wanderley, Nova Diagnostico por Imagem, Instituto do Câncer do Estado de São Paulo (ICESP), Universidade Federal da Paraiba,